(Q46464122)
Statements
Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease (English)
Matti Waterman
Miri Yavzori
Orit Picard
Ella Fudim
Halim Awadie
Batia Weiss
Yehuda Chowers
24 October 2012